TP53 and cancer: It has been reported that anti-diabetic drug, metformin, activated autophagy via mTOR inhibition and AMPK activation in p53-deficient tumor cell growth of cancer HCT116 p53+/+ and HCT116 p53−/− cell lines (Buzzai et al., 2007).